These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 18070903

  • 1. Subunit vaccine against the seven serotypes of botulism.
    Baldwin MR, Tepp WH, Przedpelski A, Pier CL, Bradshaw M, Johnson EA, Barbieri JT.
    Infect Immun; 2008 Mar; 76(3):1314-8. PubMed ID: 18070903
    [Abstract] [Full Text] [Related]

  • 2. Subunit vaccine efficacy against Botulinum neurotoxin subtypes.
    Henkel JS, Tepp WH, Przedpelski A, Fritz RB, Johnson EA, Barbieri JT.
    Vaccine; 2011 Oct 13; 29(44):7688-95. PubMed ID: 21839134
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Enhancing the protective immune response against botulism.
    Przedpelski A, Tepp WH, Kroken AR, Fu Z, Kim JJ, Johnson EA, Barbieri JT.
    Infect Immun; 2013 Jul 13; 81(7):2638-44. PubMed ID: 23670557
    [Abstract] [Full Text] [Related]

  • 5. Characterization of the antibody response to the receptor binding domain of botulinum neurotoxin serotypes A and E.
    Baldwin MR, Tepp WH, Pier CL, Bradshaw M, Ho M, Wilson BA, Fritz RB, Johnson EA, Barbieri JT.
    Infect Immun; 2005 Oct 13; 73(10):6998-7005. PubMed ID: 16177380
    [Abstract] [Full Text] [Related]

  • 6. Enhancing toxin-based vaccines against botulism.
    Przedpelski A, Tepp WH, Zuverink M, Johnson EA, Pellet S, Barbieri JT.
    Vaccine; 2018 Feb 01; 36(6):827-832. PubMed ID: 29307477
    [Abstract] [Full Text] [Related]

  • 7. Production and evaluation of a recombinant chimeric vaccine against clostridium botulinum neurotoxin types C and D.
    Gil LA, da Cunha CE, Moreira GM, Salvarani FM, Assis RA, Lobato FC, Mendonça M, Dellagostin OA, Conceição FR.
    PLoS One; 2013 Feb 01; 8(7):e69692. PubMed ID: 23936080
    [Abstract] [Full Text] [Related]

  • 8. Characterization of a novel tetravalent botulism antitoxin based on receptor-binding domain of BoNTs.
    Shi DY, Lu JS, Mao YY, Liu FJ, Wang R, Du P, Yu S, Yu YZ, Yang ZX.
    Appl Microbiol Biotechnol; 2023 May 01; 107(10):3205-3216. PubMed ID: 37058230
    [Abstract] [Full Text] [Related]

  • 9. Protective potential of recombinant non-purified botulinum neurotoxin serotypes C and D.
    Moreira C, da Cunha CE, Moreira GM, Mendonça M, Salvarani FM, Moreira ÂN, Conceição FR.
    Anaerobe; 2016 Aug 01; 40():58-62. PubMed ID: 27236078
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Development and evaluation of candidate subunit vaccine against botulinum neurotoxin serotype B.
    Shi DY, Chen BY, Mao YY, Zhou G, Lu JS, Yu YZ, Zhou XW, Sun ZW.
    Hum Vaccin Immunother; 2019 Aug 01; 15(3):755-760. PubMed ID: 30433836
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Bivalent recombinant vaccine for botulinum neurotoxin types A and B based on a polypeptide comprising their effector and translocation domains that is protective against the predominant A and B subtypes.
    Shone C, Agostini H, Clancy J, Gu M, Yang HH, Chu Y, Johnson V, Taal M, McGlashan J, Brehm J, Tong X.
    Infect Immun; 2009 Jul 01; 77(7):2795-801. PubMed ID: 19398544
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of a recombinant Hc of Clostridium botulinum neurotoxin serotype F as an effective subunit vaccine.
    Yu YZ, Li N, Wang RL, Zhu HQ, Wang S, Yu WY, Sun ZW.
    Clin Vaccine Immunol; 2008 Dec 01; 15(12):1819-23. PubMed ID: 18845829
    [Abstract] [Full Text] [Related]

  • 16. Protective efficacy of recombinant bacterin vaccine against botulism in cattle.
    Moreira C, Ferreira MRA, Finger PF, Magalhães CG, Cunha CEP, Rodrigues RR, Otaka DY, Galvão CC, Salvarani FM, Moreira ÂN, Conceição FR.
    Vaccine; 2020 Mar 04; 38(11):2519-2526. PubMed ID: 32037222
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Immune response of horses to vaccination with the recombinant Hc domain of botulinum neurotoxin types C and D.
    Stahl C, Unger L, Mazuet C, Popoff M, Straub R, Frey J.
    Vaccine; 2009 Sep 18; 27(41):5661-6. PubMed ID: 19646409
    [Abstract] [Full Text] [Related]

  • 20. Rapid immune responses to a botulinum neurotoxin Hc subunit vaccine through in vivo targeting to antigen-presenting cells.
    White DM, Pellett S, Jensen MA, Tepp WH, Johnson EA, Arnason BG.
    Infect Immun; 2011 Aug 18; 79(8):3388-96. PubMed ID: 21576339
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.